iopromide has been researched along with Angiofollicular Lymph Hyperplasia in 1 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YF | 1 |
| Zhang, WD | 1 |
| Sun, CZ | 1 |
| Ouyang, D | 1 |
| Chen, WK | 1 |
| Luo, RZ | 1 |
| Wu, MW | 1 |
1 other study available for iopromide and Angiofollicular Lymph Hyperplasia
| Article | Year |
|---|---|
Clinical features and outcomes of head and neck castleman disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Castleman Disease; Chemotherapy, | 2012 |